CCL2 and breast cancer: We have recently reported increased inflammation in BC tumors of hyperglycemic mice [27,28]: the expression of pro-inflammatory markers Il6, Ccl2, and Tnf were significantly increased in STZ-treated hyperglycemic mice and Lepr db/db mice as compared to normoglycemic control mice.